Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice

BACKGROUND AND AIM: The association of fecal calprotectin (FC) and endoscopic response in inflammatory bowel disease patients during vedolizumab (VDZ) treatment is largely unknown. The aim of this study is to assess the diagnostic value of FC to predict endoscopic response. METHODS: Patients with ac...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Gastroenterol Hepatol
Main Authors: Pauwels, Renske Wilhelmina Maria, de Vries, Annemarie Charlotte, van der Woude, Christien Janneke
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2020
主題:
Clinical Gastroenterology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7687080/
https://ncbi.nlm.nih.gov/pubmed/32291796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgh.15063
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍